Month: August 2023

ARHT Media Announces Q2 2023 Operating Results

Written by Customer Service on August 24, 2023. Posted in Earnings Releases And Operating Results.

TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, today announced its financial results for the second quarter ended June 30, 2023. Q2 2023 Financial UpdateRevenue for Q2 2023 was $2.1M compared to $2.0M for Q2 2022, a 3% increase. The increase reflects the company’s sales focus transition to fixed installations versus events, with the corresponding longer sales cycle, which is expected to positively impact the Company financials in the remaining quarters of 2023 and beyond. Q2 2023 Net loss of $2.1M vs $1.8M in Q2 2022 primarily due to increased headcount as the Company continues to invest for growth. LTM Revenue was...

Verizon Business Wins Best Microsoft Teams Solution at 2023 UC Today Awards

Written by Customer Service on August 24, 2023. Posted in Public Companies.

Verizon Mobile for Microsoft Teams seen as best-in-class for driving productivity, cost, security by leading international publication NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) — Verizon Business has been recognized by UC Today, the leading international news publication honoring excellence in Unified Communications and Collaboration, as having the “Best Solution for Microsoft Teams” at the 2023 UC Today Awards. The company’s Verizon Mobile for Microsoft Teams solution, enables businesses to use their mobile phone and business number with their Microsoft Teams phone service. In January 2023, Verizon Business became the first US carrier to support Teams Phone Mobile. With this product, businesses are able to use their business smartphones and their business numbers with their Microsoft Teams phone service. This allows for major cost...

NeurAxis Highlights Strength of its Board of Directors

Written by Customer Service on August 24, 2023. Posted in Public Companies.

CARMEL, Ind., Aug. 24, 2023 (GLOBE NEWSWIRE) — NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today highlighted the strength of its board of directors. “We are fortunate to have a board with a depth of experience in relevant areas to NeurAxis, including medical device commercialization, commercial insurance, and finance. Mitch Watkins has led several medical device companies from start-up through commercialization, Beth Keyser has served as President of Blue Cross Blue Shield Indiana at Anthem since 2020, and Tim Henrichs has been a finance executive across industries, including healthcare,” said Brian Carrico, President and Chief Executive Officer of NeurAxis. “We...

HeartSciences’ MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

Written by Customer Service on August 24, 2023. Posted in Public Companies.

Southlake, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announces that its MyoVista® wavECGTM has been selected by PanaceaFlo Ltd to be used in Dublin, Ireland in its heart screening evaluation study. The main objective of the study is to establish a cardiovascular risk screening program and integrated care hub pathway. If successful, the program is expected to roll out nationally in Ireland, in conjunction with the Irish Health Elevator Program, focusing on community-based screening and early intervention of cardiovascular risk in line with the Irish public health system...

Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis

Written by Customer Service on August 24, 2023. Posted in Public Companies.

Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY is indicated for all adult patients with Demodex blepharitis and is available via prescription from an eye care provider Sales force deployed, calling on ophthalmologists and optometrists nationwide IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced that XDEMVY™ (lotilaner ophthalmic solution) 0.25% is now available at pharmacies nationwide for prescription. The U.S. Food and Drug Administration (FDA) approved XDEMVY on July 24, 2023, for the treatment of Demodex blepharitis. “We are delighted that within...

Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials

Written by Customer Service on August 24, 2023. Posted in Public Companies.

First Antiviral Drug in GlycovirologyBOSTON, MASSACHUSETTS, Aug. 24, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral diseases, announced that it has received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA), to initiate clinical trials of ProLectin-M for the treatment of mild to moderate COVID-19 in standard risk patients. “This clearance of ProLectin-M into the clinic is very important given that this is the first of a number of indications that we intend to pursue to treat large unmet medical needs with our glycovirology technology,” said Dr Leslie Ajayi, Bioxytran Chief Medical Officer. “This is an important milestone for our Company, as it represents our...

The Healing Company Forges Strategic Partnership with Althea DRF Lifesciences

Written by Customer Service on August 24, 2023. Posted in Public Companies.

The Renowned Biosciences Research Company Expected to Propel The Healing Company’s Growth & Product Innovation New York, NY, Aug. 24, 2023 (GLOBE NEWSWIRE) — The Healing Company Inc. (OTCQB: HLCO) (“The Healing Company” or the “Company”) today announced a strategic partnership with Althea DRF Lifesciences, a renowned biosciences research center supported by the Burman family, majority shareholders of one of the largest Indian consumer packaged goods (CPG) companies and the largest Ayurvedic company worldwide with a $12 billion market capitalization. The partnership will aim to accelerate The Healing Company’s growth and product innovation as it pursues its bold vision to bring integrated healing to the world, helping millions improve their quality of life. Rooted in a shared vision of combining modern medicine with ancient...

Bright Mountain Media, Inc Announces Addition Of Renowned Global Industry Veteran In Media Services, To Its Board Of Directors

Written by Customer Service on August 24, 2023. Posted in Public Companies.

Jeff Hirsch Has 25+ Years Experience In Strategy Development, Sales Organization Structuring, International Expansion, And Marketing To Spur Growth Of Private And Public Companies Mr. Hirsch Sees A Bright Future As Bright Mountain Fills A Critical Void In Audience Targeting Boca Raton, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) — Bright Mountain Media, Inc. (OTCQB: BMTM) (“Bright Mountain” or the “Company”), a global holding company with current investments in digital publishing, advertising technology, consumer insights, and creative media services, today announced via an 8K1 that on August 15, 2023, the Board of Directors (the “Board”) of Bright Mountain Media, Inc. (the “Company”) appointed Jeff Hirsch as a director of the Company, effective as of August 15, 2023. Mr. Hirsch qualifies as an independent director under the New York Stock...

Global Biosurgery Market Size to Reach USD 19.79 Billion in 2032 | Emergen Research

Written by Customer Service on August 24, 2023. Posted in Mergers And Acquisitions.

Increasing prevalence of chronic disorders is a key factor driving market revenue growth Vancouver, Aug. 24, 2023 (GLOBE NEWSWIRE) — The global biosurgery market reached a valuation of USD 13.55 Billion in 2022. Current analysis by Emergen Research indicates that the market is poised to sustain a consistent compound annual growth rate (CAGR) of 3.8% throughout the forecast period. This growth is primarily attributed to the escalating patient demand for enhanced blood loss management and the escalating prevalence of chronic ailments. Bio-surgery involves an innovative approach termed larva or maggot therapy, which serves as a topical treatment option. This method is employed for wound healing in cases where antibiotics prove ineffective and for addressing infections. Notably, this surgical debridement technique exhibits promising...

Automotive Brake Fluid Market to Surpass 994.7 Billion by 2030 Drives Due to the Safety Imperative

Written by Customer Service on August 24, 2023. Posted in Mergers And Acquisitions.

SkyQuest projects that the automotive brake fluid market will attain a USD 994.7 billion value by 2030, with a CAGR of 2% over the forecast period (2023-2030). The automotive brake fluid market is propelled by an unyielding emphasis on safety. As vehicles become more advanced, the demand for brake fluids that meet stringent performance standards surges. This driver is rooted in the need to ensure reliable braking systems, fostering growth in the market. Westford, USA, Aug. 24, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, rapid advancements in automotive technology necessitate brake fluids that can adapt to diverse operating conditions. The automotive brake fluid market thrives on innovation, with a focus on developing fluids that resist temperature fluctuations, corrosion, and moisture. These fluids enhance overall vehicle performance...

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Month: August 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals